Female-Centric
Transforming Drug Development through a Female Perspective
Chia Chia Sun; William Freimuth, Ph.D., M.D.
Fab Biopharma
PAO-09-24-CL-03Sep 10, 2024
Exposomics
Transforming Precision Medicine through a High-Resolution Temporal Exposome Platform
Manish Arora, Ph.D.
LinusBio
PAO-09-24-CL-06Sep 05, 2024
Developability
Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform
Heonchang Lim
Samsung Biologics
PAO-09-24-CL-04Sep 04, 2024
Minitablets
Minitablets: Enhancing Safety and Palatability for Pediatric Medicines
Gus LaBella
Mikart
PAO-09-24-CL-01Aug 30, 2024
Drug Delivery
Nanocarriers to Overcome the Blood–Brain Barrier (BBB)
Serene Lee
Nice Insight
PAO-09-24-NI-01Aug 30, 2024
Comparability
Leveraging Risk Assessment for Demonstrating Product Comparability after Manufacturing Process Changes
Pawel Stanczak, Ph.D.; Xuemei Han, Ph.D.; Miguel Carrion
Tanvex CDMO
PAO-07-24-CL-08Aug 26, 2024
Real-World Data
Harnessing Longitudinal Data for Better Healthcare Outcomes in Long-Term Care
David Alvaro, Ph.D.; Brittin Wagner, Ph.D.
Pharma's Almanac
PAO-08-24-CL-09Aug 26, 2024
Digitalization
Radical Bioprocessing Efficiencies and Cost Reductions — The Next Wave of Biopharmaceutical Innovation
Michael Sokolov, Ph.D.
DataHow
PAO-08-24-CL-02Aug 26, 2024
Developability
Assessing Developability and Designing Advanceable Formulations from the Start
Nazar Elkarim, Ph.D.
Mikart
PAO-09-24-CL-02Aug 26, 2024
dbDNA
Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA
Jill Makin
Touchlight
PAO-08-24-CL-01Aug 19, 2024
IND Enablement
IND Enablement and Drug Product Development – Mitigating Risk and Accelerating through the "Valley of Death"
Johannes Clemens
Coriolis Pharma
PAO-08-24-CL-07Aug 16, 2024
Sequence Variants
Accelerating Protein Sequence Variant Analysis
Kyoungmin Lee; Yunjeong Heo; Jongbae Park
Samsung Biologics
PAO-08-24-CL-08Aug 13, 2024
Biosimilars
Biosimilars: Manufacturing and Supply Chain for Worldwide Patients
Paula Olcese
Biosidus
PAO-08-24-CL-06Aug 07, 2024
Developability
Streamlining the Path to Approval with Developability and Pre-Formulation Platforms
Andrea Hawe
Coriolis Pharma
PAO-07-24-CL-11Aug 01, 2024
CDMO Model
Rethinking the Conventional CDMO Model
Wheeler Bio
PAO-08-24-CL-04Jul 29, 2024
Regulatory
Building a Path to Approval with Effective Regulatory Support
Mira Han
Samsung Biologics
PAO-07-24-CL-12Jul 29, 2024
Multimodal Data
Why Multimodal Data is Growing In Pharma
Christian Olsen
Dotmatics
PAO-07-24-CL-13Jul 26, 2024
AAV
Overcoming Variability and Scaling Challenges in AAV Manufacturing
Rafal Garus
Viralgen Vector Core
PAO-08-24-CL-03Jul 22, 2024
Biosimilars
Pioneering Affordable Healthcare: Biosidus' Journey in Biosimilars
Hugo Sotelo; Marcelo Criscuolo
Biosidus
PAO-07-24-CL-06Jul 16, 2024
Biosimilars
Enhancing Global Access to Biotherapeutics: The Role of Biosimilars in Underserved Markets
Hugo Sotelo; Marcelo Criscuolo
Biosidus
PAO-07-24-CL-07Jul 16, 2024